Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NECT-FIELD: NECT for Stage 2 HAT
NCT00906880Phase 4Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Apr 2009
- Primary completion
- Sep 2010
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of nifurtimox, eflornithine in human African trypanosomiasis (HAT), sponsored by Drugs for Neglected Diseases initiative. Started Apr 2009; status: completed.
02
Drugs
nifurtimoxeflornithine
03
Conditions
human African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT00906880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00906880.